Conversion surgery after lenvatinib treatment for multiple lung metastases from hepatocellular carcinoma-Reference-Cited by-同舟云学术

Conversion surgery after lenvatinib treatment for multiple lung metastases from hepatocellular carcinoma

Published:2022-08-17 Issue:1 Volume:12 Page:7-13
ISSN:2192-3183
Container-title:International Cancer Conference Journal
language:en
Short-container-title:Int Canc Conf J

Author:

Sano Shunji,Asahi Yoh^ORCID,Kamiyama Toshiya,Kakisaka Tatsuhiko,Orimo Tatsuya,Nagatsu Akihisa,Aiyama Takeshi,Kazui Keizo,Shomura Hiroki,Ueki Shinya,Sakamoto Yuzuru,Shirakawa Chisato,Kamachi Hirofumi,Sugino Hirokazu,Mitsuhashi Tomoko,Taketomi Akinobu

Publisher

Springer Science and Business Media LLC

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://link.springer.com/content/pdf/10.1007/s13691-022-00567-6.pdf

Reference34 articles.

1. Kudo M, Finn RS, Qin S et al (2018) Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet 391:1163–1173. https://doi.org/10.1016/S0140-6736(18)30207-1

2. Llovet JM, Ricci S, Mazzaferro V et al (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378–390. https://doi.org/10.1056/NEJMoa0708857

3. Abbas A, Medvedev S, Shores N et al (2014) Epidemiology of metastatic hepatocellular carcinoma, a nationwide perspective. Dig Dis Sci 59:2813–2820. https://doi.org/10.1007/s10620-014-3229-9

4. Uchino K, Tateishi R, Shiina S et al (2011) Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors. Cancer 117:4475–4483. https://doi.org/10.1002/cncr.25960

5. Kojima Y, Ueno H, Okusaka T et al (2009) 6610 Hepatocellular carcinoma presenting with lung metastasis: clinical characteristics and prognostic factors. Eur J Cancer Suppl 7:393. https://doi.org/10.1016/S1359-6349(09)71331-X

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lenvatinib/sorafenib;Reactions Weekly;2023-02-25